Insider Trading History of Baker Bros. Investments, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Baker Bros. Investments, L.p. since 2013. The trader's CIK number is 1551136. At the time of the last reporting, Baker Bros. Investments, L.p. was the 10% Owner of Genomic Health Inc. (stock ticker symbol GHDX). Also see all insider trading activities at Genomic Health Inc.

Note that in the past Baker Bros. Investments, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Genomic Health Inc (GHDX) by Baker Bros. Investments, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 GHDX 0 $0 204,300 $16,353,406 0 $0
2016 GHDX 100,000 $2,701,600 0 $0 0 $0

Yearly summary of insider trading at Biocryst Pharmaceuticals Inc (BCRX) by Baker Bros. Investments, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 BCRX 1,136,364 $5,000,001 0 $0 0 $0


Insider trading activities at 2 companies by Baker Bros. Investments, L.p.:

1. Genomic Health Inc (GHDX)

2. Biocryst Pharmaceuticals Inc (BCRX)

Table 1. Insider trading of Genomic Health Inc (GHDX) by Baker Bros. Investments, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-11-13 GHDX Sale 138,712 79.67 11,051,601
2018-11-12 GHDX Sale 65,588 80.83 5,301,805
2016-08-15 GHDX Buy 100,000 27.02 2,701,600

Table 2. Insider trading of Biocryst Pharmaceuticals Inc (BCRX) by Baker Bros. Investments, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-08-01 BCRX Buy 1,136,364 4.40 5,000,001

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baker Bros. Investments, L.p. (10% Owner of Genomic Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.